Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2026 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. IBM
10. HOOD

Go back to Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2026 Financial Results

Sangamo Therapeutics (SGMO) Misses Q1 EPS by 2c

May 14, 2026 4:03 PM EDT

Sangamo Therapeutics (OTC: SGMO) reported Q1 EPS of ($0.08), $0.02 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $1.4 million.

For earnings history and earnings-related data on Sangamo Therapeutics (SGMO) click here.

... More